Related Experiment Videos
Multiplex mapping of CD4 T cell epitopes using class II tetramers.
Junbao Yang1, Eddie A James, Laurie Huston
1Benaroya Research Institute at Virginia Mason, 1201 Ninth Ave. Seattle, WA 98101, USA.
Clinical Immunology (Orlando, Fla.)
|May 9, 2006
Summary
A new multiplex tetramer-guided epitope mapping (TGEM) approach identifies CD4+ T cell epitopes presented by multiple HLA class II alleles simultaneously. This advances epitope discovery for influenza antigens in a single experiment.
Area of Science:
- Immunology
- Molecular Biology
- Vaccinology
Background:
- Tetramer-guided epitope mapping (TGEM) identifies CD4+ T cell epitopes restricted to a single MHC class II allele.
- Individuals possess multiple MHC class II alleles, necessitating methods to analyze epitopes across diverse alleles concurrently.
Purpose of the Study:
- To develop a multiplex TGEM approach for simultaneous identification of CD4+ T cell epitopes presented by multiple HLA class II alleles.
- To apply this multiplex method for discovering novel epitopes from influenza antigens.
Main Methods:
- Development of a multiplex TGEM technique utilizing multiple sets of MHC class II tetramers, each with a unique fluorescent label.
- Staining of CD4+ T cells with these multiplexed tetramers for simultaneous epitope detection.
- Application of the method to identify epitopes from influenza hemagglutinin and matrix proteins.
Main Results:
- Successful development and implementation of a multiplex TGEM approach.
- Identification of novel CD4+ T cell epitopes from influenza antigens.
- Demonstration of simultaneous epitope identification across multiple HLA class II alleles in a single experimental setting.
Conclusions:
- The multiplex TGEM approach is effective for identifying CD4+ T cell epitopes presented by multiple HLA class II alleles simultaneously.
- This method significantly enhances the efficiency of epitope discovery, particularly for complex antigens like influenza.
- The developed technique offers a powerful tool for immunological research and vaccine development.